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SUMMARY: The in vitro deiodination of I1251]-4-iodobipheny1, [1251]-4- 
iodonitrobenzene and [1251]-4-iodoaniline was investigated. No deiodination 
was detected in rat thyroid homogenates. However, at least three bio- 
deiodination mechanisms were indicated for substrates in rat liver subcellar 
fractions. Microsomal dehalogenation occurred to a minor extent with increased 
dehalogenation taking place in the cytosol fraction. The cytosol deiodination 
was extensive for 4-iodonitrobenzene and was mediated by glutathione. A sec- 
ond cytosol deiodination mechanism, not mediated by glutathione, was evident 
when 4-iodobiphenyl was the substrate. This soluble enzyme system could be 
enhanced by Arochlor 1254 or 4-iodobiphenyl pretreatment. 
INTRODUCTION: Iodinated organic compounds are used as positive X-ray contrast 
materials (1) and are becoming broadly employed as diagnostic, scanning and 
radiopharmaceutical agents (2). While there is only limited knowledge as to 
the metabolism of such compounds, it has been recognized for some time that de- 
iodination can occur with subsequent elevated serum (3), thyroid (4) and 
urine (5) iodide levels. 
The metabolism of [1251]-4-iodobipheny1 has been used in our laboratories 
as a model for in vivo biodeiodination studies (6). These studies indicate 
that 7 to 8% of the original dose appears as inorganic iodide in the urine. It 
is the purpose of this paper to describe our invitro experiments as to the mecha- 
nisms of the biodeiodination of 4-iodobiphenyl and other model compounds. 
MATERIALS AND METHODS 
Substrates: $25 I]-4-Iodobiphen 1 was obtained by an exchange reaction of 
4-iodobiphenyl (183 mg) with [ 125 II-sodium iodide (2.5 mCi) in ethylene glycol 
(6 ml) at 140°C for 24 hours. 
*To whom correspondence should be addressed. 
Abbreviations: PCB, polychlorinated biphenyl (Arochlor 1254); GSH, reduced 
gluthathione. 
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The product was extracted with benzene from the reaction mixture after the 
addition of water (6 ml) and recrystallized to constant specific activity (9.0 
HCi per mg) in methanol. Radiochemical purity of the final product (144 mg) 
was established in two TLC systems and reverse isotopic dilution indicated a 
purity of 99.7%. [1251]-4-Iodonitrobenzene was obtained in a similar manner 
with the exchange reaction at 190°C for 12 hours followed by extraction with 
CHC13 and recrystallization to constant specific activity (1.0 uCi per mg) with 
cc14. Radiochemical purity was established in two TLC systems and reverse iso- 
topic dilution indicated 97.9% purity. 
[1251]-4-Iodoaniline (0.23 uCi per mg) was labeled at 80°C for 48 hours fol- 
lowed by extraction with ether and recrystallization three times from heptane. 
TLC in two systems gave single spots. 
Liver Preparations: Male rats (Sprague Dawley 200 to 250 g) were killed in an 
ether chamber and the livers perfused with 1.15% KC1 (200 ml) before excision 
and homogenation in an equal volume of pH 7.4 phosphate buffer with a Tekmer 
Tissumizer in a cold room at 10°C. Homogenates were centrifuged at 9000 g for 
30 minutes and the supernatant centrifuged (100,000 g, 1 hr). The separated 
microsomal pellet was suspended in pH 7.4 phosphate buffer before both superna- 
tarn? (cytosol) fractions and microsomal suspensions were recentrifuged (100,000 
g, 1 hr). The washing and centrifugation were repeated before the microsomal 
pellet was reconstituted in pH 7.4 phosphate buffer in a volume equal to the 
original homogenate. 
Dialysis of Cytosol: Cell supernatant fractions prepared as above were divided 
into two portions. One portion was transferred into a 20-ml capped glass vial 
as a control and the other portion into a dialysis membrane. Solutions were im- 
mersed in distilled water (1000 ml) for 18 hours at 10°C with constant stirring. 
Precipitates from the dialysed fractions were removed by centrifugation (2000 g, 
30 min). 
Thyroid Preparations: Thyroid glands from five rats were pooled and homogenized 
in 3 volumes of pH 7.4 phosphate buffer in a glass homogenizer. The homogenates 
were centrifuged (2000 g, 30 min) and the supernatant was used without further 
processing. 
Pretreatment Studies: Rats were injected ip with either a single dose of Arochlor 
1254 (300 mg/Kg in 0.5 ml of peanut oil) 4-iodobiphenyl (100 mg/Kg) or peanut 
oil. At the end of the third day liver homogenate fractions were prepared as 
described previously. 
Incubation: Mixtures of 20 ul of an ethanol solution containing 40,000 cpm of 
one of the following substrates, [1251]-4-iodobiphenyl, [1251]-4-iodonitroben- 
zene or [1251]-4-iodoaniline, 460 ~1 of enzyme preparations and 20 1.11 of addi- 
tive solutions were incubated at 37Y! for 2 hours. The following enzyme prepa- 
rations and phosphate buffer (pH 7.4) additive solutions were used: A) the 
microsomal fraction with buffer containing MgC12 (15 u mole), nicotinamide (20 
).I mole) and NADPH (0.05 lo mole); B) cytosol and buffer without additives; C) 
cytosol and buffer containing GSH (2 to 3 mg); D) dialysed cytosol and buffer 
without additives; E) dialysed cytosol and buffer containing GSH (2 to 3 mg). 
Analytical Procedure: To stop the incubation, 20% trichloracetic acid (150 ~1) 
was added to each sample immediately after it was removed from the water bath. 
The supematant was removed after centrifugation (1700 g, 15 min), and filtered 
into a disposable culture tube. The pellet was washed with 0.5 ml of phosphate 
buffer and the supernatant wash, which was separated again by centrifugation, 
was combined with the first supernatant. The entire supernatant was spotted on 
a 4 cm wide paper strip (Whatmsn #3MM paper) and developed by descending method 
for 50 cm with n-butyl alcohol : 0.5 M NH40H : ethanol : water (20 : 20 : 2 : 1) 
(7). The paper was cut into 1 cm strips to be counted for construction of a 
chromatogram. 
RESULTS AND DISCUSSION 
While preliminary experiments with [ 1251]-4-iodobiphenyl in 2000 g liver 
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homogenates showed deiodination occurred, a comparison of incubation under high 
and low oxygen tensions did not indicate that anaerobic dehalogenation was an 
important pathway for the compound as had been reported for halothane (8) and 
DDT (9). Our in vivo studies after the administration of [1251]-4-iodobiphenyl 
to rats indicated the accumulation of [125 I] in the thyroids of these animals 
(6). However, in the present study incubations of [1251]-4-iodobiphenyl in 
2000 g thyroid tissue homogenates did not show deiodination to occur in such 
homogenates. Therefore, the accumulation of [l%] in thyroid is assumed to 
occur primarily following liver deiodination and not directly in the thyroid. 
The deiodinations occurring with [1251]-4-iodobiphenyl, [1251]-4-iodo- 
nitrobenzene or [1251]-4-iodoaniline in liver homogenates were followed more 
extensively. Trichloracetic acid precipitation of these incubations followed 
by partition paper chromatography (7) and gamma counting were used to detect 
inorganic iodide. This proved to be a suitable method to detect small amounts 
of [1251] in the presence of the large residual radioactivity due to non- 
transformed substrates. With standard solutions in zero-time control incuba- 
tions, 99.6% of [1251]-4-iodobiphenyl was precipitated and removed along with 
acid-denatured protein. Under these conditions there was a loss of only 6% of 
added [1251]. Paper chromatography then efficiently separated the [1251] from 
the remaining [1251]-4-iodobiphenyl prior to counting. Similar results were 
observed for the other two substrates. 
Our in vivo experiments with iodobiphenyl administered in three doses at 
4-day intervals indicated a self induction of its own metabolism which included 
increased yields of inorganic iodide. Therefore, transformation in normal 
liver homogenates were also compared to those occurring in liver homogenates 
obtained from rats pretreated with iodobiphenyl or with Arochlor 1254. 
The extent of deiodination in the microsomal and cytosol fractions, as 
well as the importance of GSH conjugation in deiodination was examined for the 
three [125~] labeled substrates. Results of these studies are listed in Table 
1. The relatively high control values for iodoaniline for both the microsomal 
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TABLE 1 




and cytosol fractions demonstrated spontaneous non-enzymatic deiodination for 
this compound to be important. However, enzymatic dehalogenation could not be 
established on a statistically significant basis for any of the experimental 
conditions applied to iodoaniline. 
Under the same conditions no spontaneous deiodination could be detected 
for iodobiphenyl and a low level of deiodination was found for the microsomal 
fractions from normal animals. There was a statistically significant increase 
in yield of iodide in liver microsomal preparations from iodobiphenyl or PCB 
pretreated animals @CO.005 and p< 0.0005 respectively) as compared to those 
from normal animals. Ueiodination of iodobiphenyl was even greater in the 
cytosol fraction. It is of interest that pretreatment with either iodobi- 
phenyl or PCB resulted in an increase in iodide yield over normal liver prepa- 
rations (p< 0.0005). It is also noteworthy that there was a significant 
(p< 0.0005) reduction of iodide yield with the addition of GSH to the cytosol 
incubation from the PCB pretreated animals. 
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Although deiodination of [ 1251]-4-iodonitrobenzene in the microsomal frac- 
tion of non-pretreated rats was slightly in excess of the control, this increase 
was not statistically significant due to the large variations of the control 
sample. Microsomal enzymatic activity, however, was established and was in- 
creased (p< 0.05) by PCB pretreatment. 
In the cytosol fraction, deiodination of [1251]-4-iodonitrobenzene was 
found to be much higher even prior to chemical pretreatment. PCR pretreatment 
of rats in this case did not result in a statistically significant difference in 
yield of iodide. Addition of GSH to the post-microsomal fraction from rats with 
or without PCB pretreatment increased the extent of deiodination. 
Pretreatment results showed good agreement with the established ability 
of PCB to induce microsomal enzymatic activity. While PC73 stimulation of enzy- 
matic activity in the post-microsomal fraction is not as well established, our 
results in the present study of [125 II-4-iodobiphenyl deiodination in this frac- 
tion show an increased yield of deiodination. It would be of interest to inves- 
tigate whether enzyme induction is responsible for the increased yield. 
In the past enzymatic dehalogenation in the post-microsomal fraction has 
been related to GSH conjugation. Removal of hepatic GSH content by dialysis of 
liver soluble enzyme preparations prior to incubation has been shown to impede 
this reaction (10). The reaction can be restored by the addition of GSH. In 
the present experiment, results of [1251]-4-iodobiphenyl indicated that addition 
of GSH to the PCB pretreated post-microsomal fraction actually lowered the extent 
of deiodination. These experiments were confirmed by dialysis studies with and 
without the readdition of GSH. 
Kraus (11) also observed the inhibitory effect of excess added glutathione 
to the dechlorination of cl-hexachlorocyclohexane. This study with a-hexachloro- 
cyclohexane and the present investigation indicates the presence of two dehalo- 
genating enzymes in the hepatic cytosol. One is GSH dependent, leading to dehalo, 
genation and conjugation, while the other is inhibited by GSH. 
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